Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Change In Receivables : HK$0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Sichuan Kelun-Biotech Biopharmaceutical Co Change In Receivables?

Sichuan Kelun-Biotech Biopharmaceutical Co's change in receivables for the quarter that ended in Dec. 2023 was HK$0.0 Mil. It means Sichuan Kelun-Biotech Biopharmaceutical Co's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

Sichuan Kelun-Biotech Biopharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was HK$-119.5 Mil. It means Sichuan Kelun-Biotech Biopharmaceutical Co's Accounts Receivable increased by HK$119.5 Mil from Dec. 2022 to Dec. 2023 .

Sichuan Kelun-Biotech Biopharmaceutical Co's Accounts Receivable for the quarter that ended in Dec. 2023 was HK$0.0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sichuan Kelun-Biotech Biopharmaceutical Co's liquidation value for the three months ended in Dec. 2023 was HK$1,509.0 Mil.

Sichuan Kelun-Biotech Biopharmaceutical Co Change In Receivables Historical Data

The historical data trend for Sichuan Kelun-Biotech Biopharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Kelun-Biotech Biopharmaceutical Co Change In Receivables Chart

Sichuan Kelun-Biotech Biopharmaceutical Co Annual Data

Trend

Dec21

Dec22

Dec23

Change In Receivables

-25.17

-45.93

-119.48

Sichuan Kelun-Biotech Biopharmaceutical Co Quarterly Data
	Sep21	Dec21	Jun22	Sep22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial			-	-	-	-	-

Sichuan Kelun-Biotech Biopharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sichuan Kelun-Biotech Biopharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Sichuan Kelun-Biotech Biopharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Sichuan Kelun-Biotech Biopharmaceutical Co's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2765.447	-	1290.941	+	0.75 * 0	+	0.5 * 68.943
=	1,509.0

Sichuan Kelun-Biotech Biopharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun-Biotech Biopharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 666 Xinhua Avenue, Chengdu Cross-Strait Science and Technology Industry Development Park, Wenjiang, Sichuan, Chengdu, CHN

Website

http://www.kelun-biotech.com

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an innovative biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world's prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.

Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Headlines

No Headlines